NDH.com

icon


Wolters Kluwer | Lippincott Williams & Wilkins
Drug Updates | New Drugs
orange bar


   Web Toolkit

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Drug Info and
   Nursing Links


   CE Tests

   Career Opportunities

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



bepotastine besilate
Bepreve Pharmaceutical company:
ISTA Pharmaceuticals
www.istavision.com

Pharmacologic classification: H1-receptor antagonist
Therapeutic classification:
antihistamine
Pregnancy risk category:
C


AVAILABLE FORMS
Ophthalmic solution: 1.5%

INDICATIONS AND DOSAGES
Itching associated with conjunctivitis—
Adults: Instill 1 drop into affected eye b.i.d.

CONTRAINDICATIONS AND CAUTIONS
None reported.

INTERACTIONS
None reported.

ADVERSE REACTIONS
CNS: headache.
EENT: eye irritation, mild taste after instillation, nasopharyngitis.

Reactions may be common, uncommon, life-threatening, or
COMMON AND LIFE-THREATENING.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2010 by Lippincott Williams & Wilkins